Imagine a world where access to life-saving HIV treatments and research opportunities were out of reach for millions. This was the harsh reality before trailblazers like Richard Jefferys stepped in. On November 17th, 2025, at 6:30 pm EST, Jefferys, a renowned activist and director of the Basic Science, Vaccines and Cure Project at the Treatment Action Group (TAG), will deliver the 29th Annual Jonathan Lax Memorial Lecture at The Wistar Institute. This prestigious event, honoring his tireless efforts, will be livestreamed globally, offering a unique opportunity to hear from a true changemaker. But here's where it gets even more inspiring: Jefferys' journey began in the mid-90s, amidst the height of the AIDS crisis, when fear and stigma were rampant. He dedicated his life to fighting for access to medications, clinical trials, and essential services for those living with HIV/AIDS. His work helped lay the foundation for global initiatives like the Health GAP Coalition, which strives to ensure equitable access to HIV treatments worldwide, particularly in underserved regions.
This year's Wistar Legacy Awards also shine a light on local heroes. Philadelphians Jay Kostman, M.D., and Robb Reichard will be recognized for their unwavering commitment to the community. Dr. Kostman, chief medical officer at Philadelphia FIGHT, has been instrumental in advancing Wistar’s HIV research for over 25 years. Reichard, a leader of the AIDS Fund, has tirelessly supported vulnerable individuals through grants, financial aid, and educational programs.
Jeffreys’ lecture, “Community Advocacy and HIV Cure-Directed Research,” promises to be a powerful reflection on his 30+ years of advocacy. He’ll delve into his efforts to secure funding for HIV/AIDS research, raise awareness about clinical trials, and develop more affordable, less toxic treatments—all with the ultimate goal of finding a cure.
“Jonathan Lax was a beacon of hope during the darkest days of the AIDS epidemic,” Jefferys reflects. “His legacy, and the grassroots movements he inspired, like ACT-UP Philadelphia, fueled my passion for this work. But the fight is far from over. We need more innovative research, better healthcare access, and a global commitment to ending HIV.”
Luis J. Montaner, D.V.M., D.Phil., Wistar’s EVP and a leading HIV researcher, praises Jefferys’ impact: “Richard has revolutionized how we approach HIV. He’s not just advocating for better treatments; he’s making cutting-edge science accessible to everyone. His work is paving the way for breakthroughs that could lead to a cure.”
The Jonathan Lax Memorial Lecture, established after Lax’s passing, has become a platform for visionary leaders in the HIV/AIDS field. Past speakers include Nobel Laureates Drew Weissman and Françoise Barré-Sinoussi, as well as Anthony S. Fauci, former director of the National Institute of Allergy and Infectious Diseases.
But here’s the controversial part: While Jefferys’ work has undeniably transformed HIV advocacy, some argue that the pace of progress remains too slow. Are we doing enough to ensure equitable access to treatments globally? And what role should governments and pharmaceutical companies play in accelerating research and affordability?
The 2025 lecture is free and open to all. Register now [https://cvent.me/eAVqGP] to be part of this pivotal conversation. Let’s continue the fight—together.
What do you think? Is the world moving fast enough to end HIV? Share your thoughts in the comments below.
